Myelofibrosis and Polycythemia Vera: Current and Emerging Treatment Options

This comprehensive program gathers insight from 5 experts to improve the skills of clinicians who treat patients with myeloproliferative neoplasms, particularly myelofibrosis and polycythemia vera. All aspects of this program are designed to complement each other, including an Interactive Treatment Decision Support Tool, an expert-authored commentary and module, and a downloadable slideset.
Brady L. Stein, MD, MHS


In this commentary, I highlight study findings from the 2016 Hematology meeting that may affect management of patients with myelofibrosis or polycythemia vera.

Brady L. Stein, MD, MHS Released: December 30, 2016
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by an educational grant from

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?